These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17460149)

  • 1. sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart.
    Monassier L; Manoury B; Bellocq C; Weissenburger J; Greney H; Zimmermann D; Ehrhardt JD; Jaillon P; Baró I; Bousquet P
    J Pharmacol Exp Ther; 2007 Jul; 322(1):341-50. PubMed ID: 17460149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
    Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
    J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clebopride, antidopaminergic gastrointestinal prokinetics, on cardiac repolarization.
    Kim KS; Shin WH; Park SJ; Kim EJ
    Int J Toxicol; 2007; 26(1):25-31. PubMed ID: 17365143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of
    Furutani K; Tsumoto K; Chen IS; Handa K; Yamakawa Y; Sack JT; Kurachi Y
    J Gen Physiol; 2019 Feb; 151(2):214-230. PubMed ID: 30674563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells.
    Liu H; Yang L; Chen KH; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
    Pharmacol Res; 2016 Feb; 104():61-9. PubMed ID: 26689773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
    Wu L; Rajamani S; Li H; January CT; Shryock JC; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1048-57. PubMed ID: 19592609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential.
    Himmel HM
    J Pharmacol Toxicol Methods; 2007; 56(2):145-58. PubMed ID: 17590357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
    Rampe D; Murawsky MK; Grau J; Lewis EW
    J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection by eukaryotic expression vector pcDNA3-HERG inhibits the cultured neonatal rabbit ventricular myocyte hypertrophy induced by phenylephrine.
    Zhao Y; Xu Y; Cui C; Li Y; Zeng Y
    Cardiovasc Pathol; 2012; 21(4):339-45. PubMed ID: 22100990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition.
    Lin C; Ke X; Ranade V; Somberg J
    Cardiology; 2008; 110(3):145-52. PubMed ID: 18057881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
    Larsen AP; Olesen SP; Grunnet M; Poelzing S
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The D3-dopaminergic agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) increases cardiac action potential duration and blocks human ether-a-go-go-related gene K+ channel.
    Torres-Jácome J; Tejeda-Chávez HR; Rodríguez-Menchaca AA; Sánchez-Chapula JA; Navarro-Polanco RA
    J Cardiovasc Pharmacol; 2006 May; 47(5):656-62. PubMed ID: 16775504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization.
    Lee HA; Kim EJ; Hyun SA; Park SG; Kim KS
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):614-8. PubMed ID: 20406211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobutinol delays ventricular repolarization in the guinea pig heart: comparison with cardiac effects of HERG K+ channel inhibitor E-4031.
    Takahara A; Sasaki R; Nakamura M; Sendo A; Sakurai Y; Namekata I; Tanaka H
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):552-9. PubMed ID: 19770670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
    Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.